Reshma Kewalramani is the Chief Executive Officer and President at Vertex Pharmaceuticals, a global biotechnology company. Based in Boston, USA.
Reshma Kewalramani is the Chief Executive Officer and President at Vertex Pharmaceuticals, a global biotechnology company. She trained in internal medicine and nephrology before joining the biopharmaceutical industry. She joined Vertex in 2017, became Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs, and was appointed CEO in 2020. Vertex focuses on discovering and developing new medicines, including treatments for cystic fibrosis, pain, sickle cell disease, and beta thalassemia.
Full founder directory · Investor directory · Company funding database · Fundraising library